EPCAM (Epithelial Cell Adhesion Molecule) was initially identified asa tumor antigen in colorectal carcinomas and serves as a prognosticmarker for disseminated tumor cells, which are considered the majorsource for metastatic cancer cells.63 Itshigh expression in bone cells has been reported rarely. Here, EPCAM is linked to colorectal carcinoma.